Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2006-05-22 14:17:45 UTC |
---|
Update Date | 2022-11-30 19:02:44 UTC |
---|
HMDB ID | HMDB0002262 |
---|
Secondary Accession Numbers | - HMDB0006739
- HMDB02262
- HMDB06739
|
---|
Metabolite Identification |
---|
Common Name | CE(12:0) |
---|
Description | Cholesteryl lauric acid is a cholesteryl ester. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). Lauric acid greatly increases total cholesterol, but much of its effect is on HDL cholesterol. Consequently, oils rich in lauric acid decrease the ratio of total to HDL cholesterol. (PMID:12716665 , 8644684 , 10030391 ). |
---|
Structure | [H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)CCCCCCCCCCC)[C@H](C)CCCC(C)C InChI=1S/C39H68O2/c1-7-8-9-10-11-12-13-14-15-19-37(40)41-32-24-26-38(5)31(28-32)20-21-33-35-23-22-34(30(4)18-16-17-29(2)3)39(35,6)27-25-36(33)38/h20,29-30,32-36H,7-19,21-28H2,1-6H3/t30-,32+,33+,34-,35+,36+,38+,39-/m1/s1 |
---|
Synonyms | Value | Source |
---|
12:0 cholesterol ester | Lipid Annotator, HMDB | 1-dodecanoyl-cholesterol | Lipid Annotator, HMDB | cholesteryl 1-dodecanoate | Lipid Annotator, HMDB | Cholesterol Ester(12:0) | Lipid Annotator, HMDB | CE(12:0) | Lipid Annotator | CE(12:0/0:0) | Lipid Annotator, HMDB | cholesterol 1-dodecanoic acid | Lipid Annotator, HMDB | Cholesterol Ester(12:0/0:0) | Lipid Annotator, HMDB | cholesterol 1-dodecanoate | Lipid Annotator, HMDB | cholesteryl 1-dodecanoic acid | Lipid Annotator, HMDB | (3beta)-Cholest-5-en-3-ol dodecanoate | HMDB | (3beta)-Cholest-5-en-3-ol dodecanoic acid | HMDB | Cholest-5-en-3-beta-yl laurate | HMDB | Cholest-5-en-3-yl laurate | HMDB | Cholest-5-en-3b-ol dodecanoate | HMDB | Cholest-5-en-3b-ol dodecanoic acid | HMDB | Cholest-5-en-3beta-ol dodecanoate | HMDB | Cholest-5-en-3beta-ol dodecanoic acid | HMDB | Cholest-5-en-3beta-yl dodecanoate | HMDB | Cholest-5-en-3beta-yl dodecanoic acid | HMDB | Cholesterol laurate | HMDB | Cholesteryl dodecanoate | HMDB | Cholesteryl dodecanoic acid | HMDB | Cholesteryl laurate | HMDB | Cholesteryl lauric acid | HMDB | Dodecanoate | HMDB | Dodecanoic acid | HMDB | Dodecanoic acid cholesteryl ester | HMDB |
|
---|
Chemical Formula | C39H68O2 |
---|
Average Molecular Weight | 568.956 |
---|
Monoisotopic Molecular Weight | 568.52193142 |
---|
IUPAC Name | (1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl dodecanoate |
---|
Traditional Name | (1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl dodecanoate |
---|
CAS Registry Number | 1908-11-8 |
---|
SMILES | [H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)CCCCCCCCCCC)[C@H](C)CCCC(C)C |
---|
InChI Identifier | InChI=1S/C39H68O2/c1-7-8-9-10-11-12-13-14-15-19-37(40)41-32-24-26-38(5)31(28-32)20-21-33-35-23-22-34(30(4)18-16-17-29(2)3)39(35,6)27-25-36(33)38/h20,29-30,32-36H,7-19,21-28H2,1-6H3/t30-,32+,33+,34-,35+,36+,38+,39-/m1/s1 |
---|
InChI Key | RMLFYKFCGMSLTB-ZBDFTZOCSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Steroid esters |
---|
Direct Parent | Cholesteryl esters |
---|
Alternative Parents | |
---|
Substituents | - Cholesteryl ester
- Cholesterol
- Cholestane-skeleton
- Delta-5-steroid
- Carboxylic acid ester
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | |
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
General References | - Mensink RP, Zock PL, Kester AD, Katan MB: Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003 May;77(5):1146-55. [PubMed:12716665 ]
- Temme EH, Mensink RP, Hornstra G: Comparison of the effects of diets enriched in lauric, palmitic, or oleic acids on serum lipids and lipoproteins in healthy women and men. Am J Clin Nutr. 1996 Jun;63(6):897-903. [PubMed:8644684 ]
- Lagrost L, Mensink RP, Guyard-Dangremont V, Temme EH, Desrumaux C, Athias A, Hornstra G, Gambert P: Variations in serum cholesteryl ester transfer and phospholipid transfer activities in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids. Atherosclerosis. 1999 Feb;142(2):395-402. [PubMed:10030391 ]
|
---|